Abstract
Background and aims The relationships between obesity-related traits and the brain’s white matter characteristics and the context of sex- and age-related differences, remain unclear. This study aims to elucidate these body-brain connections using a large-scale dataset.
Methods We analyzed data from 40,040 participants from the UK Biobank (52.2% female; ages 44-83 years) using multiple linear regression to evaluate associations between obesity-related traits (obesity, body anthropometrics) and white matter diffusion tensor imaging (DTI) metrics (fractional anisotropy, axial diffusivity, radial diffusivity, mean diffusivity). We also examined interactions with age and sex.
Results Our analyses revealed significant associations between obesity-related traits and DTI metrics with partial correlation coefficient |r| effect sizes ranging from 0.02 to 0.20 for most regions of interest with largest effects in brainstem tracts. We observed more widespread sex-by-obesity-related than age-by-obesity-related interaction effects on DTI metrics.
Conclusions Our results link obesity-related traits and white matter phenotypes, suggesting that shared body fat-related pathways linking physical and brain health that may vary based on sex and age. Understanding these relationships could enhance the development and evaluation of targeted, individualized, treatment strategies for conditions that co-occur with obesity, although further longitudinal studies are needed to map the dynamics of these associations.
Competing Interest Statement
OAA has received a speaker's honorarium from Lundbeck, Sunovion, Otsuka, and Janssen and is a consultant to Cortechs.ai. The remaining authors declare no conflict of interest.
Funding Statement
We obtained funding from The Research Council of Norway (#223273, #288083, #323951); South-Eastern Norway Regional Health Authority (#2017112, #2021070, #2022080, #2023012, #500189); German Federal Ministry of Education and Research (BMBF, #01ZX1904A); the Swiss National Science Foundation (PZ00P3_193658), European Union's Horizon2020 Research and Innovation Programme (CoMorMent project; Grant #847776) & European Research Council (ERC) StG (Grant #802998).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UK Biobank has IRB approval from the North-West Multi-center Research Ethics Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The UK Biobank resource is open for eligible researchers upon application (http://www.ukbiobank.ac.uk/register-apply/).
